Search results for "Hanmi Group"

Hanmi Group Unveils ‘Anne’ Character to Unify Popular OTC Brand Lineup

Hanmi Group Unveils ‘Anne’ Character to Unify Popular OTC Brand Lineup

Sore-throat spray "Mok-Anne" and artificial tear formula "Nun-Anne"—two familiar over-the-counter products in South Korea—now have a unified brand...
[Reporter’s Notebook] Hanmi Group’s Internal Feuds Keep Invoking the ‘Lim Sung-ki Spirit.’ It Must Apply to Everyone

[Reporter’s Notebook] Hanmi Group’s Internal Feuds Keep Invoking the ‘Lim Sung-ki Spirit.’ It Must Apply to Everyone

Whenever a control dispute or internal conflict erupts at Hanmi Group, one phrase reliably resurfaces: the “Lim Sung-ki spirit.
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
Early Flu Outbreak Shifts Demand to Ibuprofen-Based Cold Remedies as Hanmi Leads Market

Early Flu Outbreak Shifts Demand to Ibuprofen-Based Cold Remedies as Hanmi Leads Market

With wide daily temperature fluctuations causing seasonal influenza to spread nearly a month earlier than usual in...
Hanmi Science Takes Derma Cosmetics Brand ADESII to Seongsu, Expanding B2C Beauty Reach

Hanmi Science Takes Derma Cosmetics Brand ADESII to Seongsu, Expanding B2C Beauty Reach

Hanmi Science is stepping up its consumer-facing beauty push, bringing its derma cosmetics brand ADESII front and...
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Hanmi Control Dispute Reignites as Court Freezes 10 Billion Won in Lim Ju-hyun’s Shares

Hanmi Control Dispute Reignites as Court Freezes 10 Billion Won in Lim Ju-hyun’s Shares

The "four-party alliance" formed to stabilize management control at Hanmi Pharmaceutical Group has descended into open...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...